Navigation Links
Video: Turning Hope Into Reality - VA Research to Restore Veterans' Abilities
Date:4/29/2009

WASHINGTON, April 29 /PRNewswire/ -- VA Research is dedicated to restoring injured Veterans to their greatest possible functional capacity in their families, communities, and work places. For those who lost limbs from combat traumas or because of complications such as diabetes, VA researchers are designing and building lighter, more lifelike prostheses using leading-edge technologies such as robotics, tissue engineering, and nanotechnology, and are studying how to best match available prosthetic components to the needs of amputees.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/veteransprosthetics/38101/

An example of VA's pioneering research in the field of prosthetics: VA is launching a three-year study of an artificial arm that allows those who have lost their limb to perform tasks such as picking up a key, holding a pencil, or using a power drill. The study will allow engineers to refine the prototype of the artificial arm, which was developed through the Defense Advanced Research Projects Agency (DARPA), before it is commercialized and made available through the VA health care system.

"The advanced prosthetic arm is a high-tech example of how VA researchers are continually modernizing the materials and design of artificial limbs to meet Veterans' lifestyle and medical needs," says Joel Kupersmith, M.D., VA's Chief Research and Development Officer.

The impending three-year "optimization study" of the artificial arm is the first large-scale clinical trial to play an integral part in the final design and development of a prosthetic device, says Michael Selzer, M.D., VA's Director of Rehabilitation Research and Development. At the end of the two-year effort, Selzer says, "The arm will have been optimized to the point where it can be manufactured and made available to our Veterans."
'/>"/>

SOURCE Department of Veterans Affairs
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
2. Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimers Disease
3. Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin
4. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
5. Video: 8-Minute Film Documentary Explores Why Humans Age
6. Video: Insulet Unveils Video Contest for OmniPod Users
7. Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project
8. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
9. Video: Women Unsatisfied With Body and Breasts, Less Likely to Comply With Screenings, Including Mammography
10. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
11. Video: Fortune 1000 Executives: New President Must Fix Education Gap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ...
(Date:1/14/2014)... 13, 2014 Bob Hainsey, a semiconductor ... 20 years in the industry, has joined SPIE, ... will serve as the society’s Science and Technology Strategist. ... SPIE as our Technology Strategist, further strengthening the technical ...
(Date:1/14/2014)... During the 1600’s through the 1800’s doctors contributed ... In this time period, doctors did not know that they ... the death of vulnerable patients. In the same way, medical ... be unwittingly transmitting herpes viruses to their patients. The CBCD ...
(Date:1/14/2014)... Triangle Park, NC (PRWEB) January 14, 2014 ... company focusing on ultra-sensitive POC diagnostic platforms and novel disease ... their first round of financing netting a total of $690,000. ... outside equity capital in the company. This group of private ...
Breaking Biology Technology:Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3BioMedomics, Inc. Closes $690K Round of Financing 2
... 11 Alimera Sciences Inc., a privately held,biopharmaceutical ... of prescription ophthalmic pharmaceuticals, today reported,that enrollment has ... safety and efficacy,of Iluvien(TM) in patients with bilateral ... , The ...
... Shareholder Value , , CHICAGO, Dec. ... affiliates, of nearly 29% of the outstanding shares of common stock ... it had delivered a letter to Avigen,s Board of Directors expressing ... value. , , The ...
... today that they continue to penetrate and build market share in ... energy by working with companies like Southwest Windpower, MiaSole, Solyndra, Santur ... ... December 11, 2008 -- DAZ Systems, Inc. , announced today ...
Cached Biology Technology:Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD 2Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 2Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 3Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 4Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 5DAZ Systems, Inc. Thrives in the Clean Energy Industry 2DAZ Systems, Inc. Thrives in the Clean Energy Industry 3
(Date:4/17/2014)... infection , Respiratory syncytial virus (RSV) is ... generating life-threating illness in very young and elderly ... RSV enters host cells through the fusion protein ... Small interfering peptides that prevent bundle formation limit ... highly susceptible to degradation. In this issue of ...
(Date:4/17/2014)... modeling study suggests that fish consumption advisories for ... to long-lived contaminants like persistent organic pollutants (POPs). ... of researchers including University of Toronto Scarborough PhD ... at how different levels of environmental contamination, a ... chemicals in the body influenced exposure in her ...
(Date:4/17/2014)... Our eyes not ... with a continuous stream of information about our own movements. ... a car the world glides by us and leaves ... our brain calculates self-motion from this "optic flow". This way, ... during our own movements. Together with biologists from the University ...
Breaking Biology News(10 mins):JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6Fish consumption advisories fail to cover all types of contaminants 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4
... patients with epilepsy carry might enable doctors to better ... seizures, suggest basic findings by researchers at the Duke ... the University College London. Patients often undergo a lengthy ... of anti-epilepsy drugs appropriate for them. , The researchers ...
... lymphocytic leukemia (B-CLL),is the most common leukemia in ... mature B lymphocytes in the blood, bone,marrow, and ... early stages,of disease, B-CLL is the result of ... normal B cell death (apoptosis). Livio,Trentin and colleagues ...
... expert manipulators when it comes to co-opting their host's ... from the vast repertoire of proteins and mechanisms dedicated ... like HIV have evolved myriad ways of redirecting that ... eukaryotes have three types of RNA polymerases, each charged ...
Cached Biology News:Gene variations explain drug dose required to control seizures 2Gene variations explain drug dose required to control seizures 3Gene variations explain drug dose required to control seizures 4An HIV Protein Plays a Surprising Role in Gene Activation 2An HIV Protein Plays a Surprising Role in Gene Activation 3